Funda Meric‐Bernstam

739 total citations
11 papers, 560 citations indexed

About

Funda Meric‐Bernstam is a scholar working on Cancer Research, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Funda Meric‐Bernstam has authored 11 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Pathology and Forensic Medicine and 4 papers in Surgery. Recurrent topics in Funda Meric‐Bernstam's work include Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (6 papers) and BRCA gene mutations in cancer (4 papers). Funda Meric‐Bernstam is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (6 papers) and BRCA gene mutations in cancer (4 papers). Funda Meric‐Bernstam collaborates with scholars based in United States. Funda Meric‐Bernstam's co-authors include Kelly K. Hunt, Henry M. Kuerer, Gildy V. Babiera, S. Eva Singletary, Ayşegül A. Şahin, Isabelle Bedrosian, Merrick I. Ross, Thomas A. Buchholz, Frederick C. Ames and Deepak Sagaram and has published in prestigious journals such as Cancer and Annals of Oncology.

In The Last Decade

Funda Meric‐Bernstam

11 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Funda Meric‐Bernstam United States 10 354 227 204 159 119 11 560
Rowena Mercado United States 13 188 0.5× 440 1.9× 352 1.7× 75 0.5× 171 1.4× 18 634
Kristalyn K. Gallagher United States 14 314 0.9× 211 0.9× 257 1.3× 228 1.4× 13 0.1× 52 596
Susan Tinley United States 13 112 0.3× 329 1.4× 240 1.2× 83 0.5× 490 4.1× 35 824
Nora E Carbine United States 4 303 0.9× 74 0.3× 165 0.8× 183 1.2× 380 3.2× 6 574
Emily Glogowski United States 14 88 0.2× 152 0.7× 97 0.5× 73 0.5× 172 1.4× 27 530
Jeremy S. H. Jackson Canada 13 472 1.3× 298 1.3× 462 2.3× 240 1.5× 53 0.4× 19 864
Carlie K. Thompson United States 10 219 0.6× 76 0.3× 245 1.2× 126 0.8× 107 0.9× 18 472
Preeti Subhedar United States 12 240 0.7× 115 0.5× 247 1.2× 108 0.7× 34 0.3× 29 448
J Hirshfield-Bartek United States 6 207 0.6× 53 0.2× 162 0.8× 88 0.6× 155 1.3× 12 385
Tomasz Czechura United States 9 430 1.2× 145 0.6× 149 0.7× 318 2.0× 213 1.8× 10 574

Countries citing papers authored by Funda Meric‐Bernstam

Since Specialization
Citations

This map shows the geographic impact of Funda Meric‐Bernstam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Funda Meric‐Bernstam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Funda Meric‐Bernstam more than expected).

Fields of papers citing papers by Funda Meric‐Bernstam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Funda Meric‐Bernstam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Funda Meric‐Bernstam. The network helps show where Funda Meric‐Bernstam may publish in the future.

Co-authorship network of co-authors of Funda Meric‐Bernstam

This figure shows the co-authorship network connecting the top 25 collaborators of Funda Meric‐Bernstam. A scholar is included among the top collaborators of Funda Meric‐Bernstam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Funda Meric‐Bernstam. Funda Meric‐Bernstam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Bedrosian, Isabelle, Gildy V. Babiera, Elizabeth A. Mittendorf, et al.. (2010). A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer. 116(11). 2543–2548. 66 indexed citations
3.
Bernstam, Elmer V., et al.. (2008). Commonly cited website quality criteria are not effective at identifying inaccurate online information about breast cancer. Cancer. 112(6). 1206–1213. 83 indexed citations
4.
Akçakanat, Argun, et al.. (2008). Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases. Cancer. 112(11). 2352–2358. 51 indexed citations
5.
Boughey, Judy C., Janice N. Cormier, Yan Xing, et al.. (2007). Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer. 110(11). 2542–2550. 16 indexed citations
6.
Peintinger, Florentia, W. Fraser Symmans, Ana M. Gonzalez‐Angulo, et al.. (2006). The safety of breast‐conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer. 107(6). 1248–1254. 38 indexed citations
7.
Boughey, Judy C., Nazanin Khakpour, Funda Meric‐Bernstam, et al.. (2006). Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer. 107(7). 1440–1447. 61 indexed citations
8.
Uyei, Anne, Susan K. Peterson, Julie Erlichman, et al.. (2006). Association between clinical characteristics and risk‐reduction interventions in women who underwent BRCA1 and BRCA2 testing. Cancer. 107(12). 2745–2751. 57 indexed citations
9.
Chagpar, Anees B., Lavinia P. Middleton, Ayşegül A. Şahin, et al.. (2005). Clinical outcome of patients with lymph node‐negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer. 103(8). 1581–1586. 77 indexed citations
10.
Cabıoğlu, Neslihan, Kelly K. Hunt, Thomas A. Buchholz, et al.. (2005). Improving local control with breast‐conserving therapy. Cancer. 104(1). 20–29. 76 indexed citations
11.
Shen, Jeannie, Kelly K. Hunt, Nadeem Q. Mirza, et al.. (2005). Predictors of systemic recurrence and disease‐specific survival after ipsilateral breast tumor recurrence. Cancer. 104(3). 479–490. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026